From: Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations
HHT patients
Count
42
BAVM (y), n/total (%)
20/42 (48)
PAVM (y), n/total (%)
30/42 (71)
GI bleeding (y), n/total (%)
9/42 (21)
Symptomatic LVM (y), n/total (%)*
3/37 (8)